Longer Interval Between Neoadjuvant Chemoradiotherapy and Surgery is Associated with Improved Pathological Response, but Does Not Accurately Estimate Survival in Patients with Resectable Esophageal Cancer.
ONCOLOGY LETTERS（2023）
Key words
esophageal cancer,neoadjuvant chemoradiotherapy,optimal time interval,pathological response,survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined